Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Vaillant

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Gastroenterology|September 24, 2020
ReplyAndrew Vaillant,
Gastroenterology|September 15, 2020
Clarifying the Chemistry, Activity, and Safety of Nucleic Acid PolymersAndrew Vaillant
Journal of Hepatology|September 18, 2022
Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?Andrew Vaillant
The Lancet. Infectious Diseases|March 6, 2019
Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?Andrew Vaillant
ACS Infectious Diseases|December 11, 2020
HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus InfectionAndrew Vaillant
Viruses|September 23, 2022
Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral EffectsAndrew Vaillant
The New England Journal of Medicine|March 22, 2023
Efficacy and Safety of Bepirovirsen in Hepatitis BAndrew Vaillant
Viruses|April 30, 2021
Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional CureAndrew Vaillant
ACS Infectious Diseases|September 11, 2018
REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV InfectionAndrew Vaillant
Antiviral Research|July 13, 2016
Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infectionAndrew Vaillant
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Gastroenterology|September 24, 2020
ReplyAndrew Vaillant,
Gastroenterology|September 15, 2020
Clarifying the Chemistry, Activity, and Safety of Nucleic Acid PolymersAndrew Vaillant
Journal of Hepatology|September 18, 2022
Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?Andrew Vaillant
The Lancet. Infectious Diseases|March 6, 2019
Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?Andrew Vaillant
ACS Infectious Diseases|December 11, 2020
HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus InfectionAndrew Vaillant
Viruses|September 23, 2022
Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral EffectsAndrew Vaillant
The New England Journal of Medicine|March 22, 2023
Efficacy and Safety of Bepirovirsen in Hepatitis BAndrew Vaillant
Viruses|April 30, 2021
Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional CureAndrew Vaillant
ACS Infectious Diseases|September 11, 2018
REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV InfectionAndrew Vaillant
Antiviral Research|July 13, 2016
Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infectionAndrew Vaillant
Pageof 6